Vertex Pharmaceuticals Company Profile (NASDAQ:VRTX)

About Vertex Pharmaceuticals

Vertex Pharmaceuticals logoVertex Pharmaceuticals Incorporated is engaged in the business of discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company operates in pharmaceuticals segment. Its business is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. Its marketed medicines are ORKAMBI and KALYDECO, which are approved to treat patients with CF having specific mutations in their CF transmembrane conductance regulator (CFTR) gene. It has multiple development programs in the field of CF, including VX-661, VX-371, and VX-152 and VX-440. It is engaged in various other research and mid- and early-stage development programs, such as programs in the areas of oncology, pain and neurology. Its oncology drug candidates include VX-970, VX-803 and VX-984; pain drug candidates include VX-150 and VX-241, and acute spinal cord injury drug candidate include VX-210.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: VRTX
  • CUSIP: 92532F10
Key Metrics:
  • Previous Close: $87.21
  • 50 Day Moving Average: $95.19
  • 200 Day Moving Average: $89.63
  • 52-Week Range: $75.90 - $134.71
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 29.87
  • P/E Growth: 1.69
  • Market Cap: $21.61B
  • Outstanding Shares: 247,778,000
  • Beta: 0.46
Profitability:
  • Net Margins: -17.77%
  • Return on Equity: -12.34%
  • Return on Assets: -5.52%
Debt:
  • Debt-to-Equity Ratio: 0.09%
  • Current Ratio: 2.33%
  • Quick Ratio: 2.23%
Additional Links:
Companies Related to Vertex Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) (?)
Ratings Breakdown: 10 Hold Ratings, 15 Buy Ratings
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $119.84 (37.42% upside)

Analysts' Ratings History for Vertex Pharmaceuticals (NASDAQ:VRTX)
Show:
DateFirmActionRatingPrice TargetDetails
9/30/2016Jefferies GroupReiterated RatingBuy$107.00 -> $104.00View Rating Details
9/30/2016Leerink SwannReiterated RatingOutperformView Rating Details
9/30/2016Robert W. BairdReiterated RatingNeutral$128.00 -> $115.00View Rating Details
9/28/2016Credit Suisse Group AGSet Price TargetBuy$110.00View Rating Details
9/29/2016Stifel NicolausSet Price TargetBuy$109.00View Rating Details
9/29/2016Maxim GroupReiterated RatingHoldView Rating Details
9/15/2016BMO Capital MarketsReiterated RatingHold$87.00View Rating Details
9/13/2016Citigroup Inc.Initiated CoverageMarket PerformView Rating Details
9/13/2016Raymond James Financial Inc.Initiated CoverageMarket PerformView Rating Details
8/16/2016RBC Capital MarketsReiterated RatingBuyView Rating Details
8/16/2016JMP SecuritiesReiterated RatingBuyView Rating Details
7/31/2016JPMorgan Chase & Co.Reiterated RatingBuyView Rating Details
7/28/2016Cowen and CompanyReiterated RatingHoldView Rating Details
7/28/2016Morgan StanleyLower Price TargetOverweight$140.00 -> $139.00View Rating Details
6/18/2016Piper Jaffray Cos.Reiterated RatingBuyView Rating Details
4/28/2016Needham & Company LLCReiterated RatingHoldView Rating Details
4/28/2016HC WainwrightReiterated RatingBuy$155.00View Rating Details
4/28/2016Barclays PLCLower Price TargetOverweight$135.00 -> $110.00View Rating Details
4/28/2016Goldman Sachs Group Inc.DowngradeBuy -> Neutral$109.00 -> $88.00View Rating Details
4/28/2016Royal Bank Of CanadaLower Price TargetOutperform$135.00 -> $115.00View Rating Details
3/28/2016GuggenheimLower Price TargetBuy$145.00 -> $114.00View Rating Details
3/15/2016Bank of America Corp.Reiterated RatingNeutral$108.00View Rating Details
2/11/2016Oppenheimer Holdings Inc.Initiated CoverageMarket PerformView Rating Details
2/4/2016ArgusLower Price TargetBuy$154.00 -> $140.00View Rating Details
10/27/2015William BlairReiterated RatingBuy$158.00View Rating Details
9/15/2015NomuraInitiated CoverageBuy$162.00View Rating Details
7/31/2015Deutsche Bank AGReiterated RatingBuy$155.00View Rating Details
7/7/2015BTIG ResearchLower Price TargetBuy$200.00 -> $180.00View Rating Details
6/5/2015Canaccord GenuityReiterated RatingBuy$150.00View Rating Details
1/9/2015Janney Montgomery ScottInitiated CoverageNeutral$126.00View Rating Details
11/5/2014CRT CapitalInitiated CoverageBuy$175.00View Rating Details
10/13/2014Wells Fargo & Co.UpgradeNeutral -> Outperform$129.00 -> $125.00View Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for Vertex Pharmaceuticals (NASDAQ:VRTX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/26/2016        
7/27/2016Q216$0.21$0.24$428.08 million$431.61 millionViewListenView Earnings Details
4/27/2016Q116$0.29$0.09$439.94 million$398.10 millionViewListenView Earnings Details
1/27/2016Q4$0.17$0.17$406.30 million$417.94 millionViewListenView Earnings Details
10/28/2015Q315($0.60)($0.13)$245.84 million$309.82 millionViewListenView Earnings Details
7/29/2015Q215($0.58)($0.54)$149.49 million$166.00 millionViewListenView Earnings Details
4/29/2015Q115($0.75)($0.62)$142.38 million$138.51 millionViewListenView Earnings Details
1/28/2015Q414($0.65)($0.55)$137.50 million$144.56 millionViewListenView Earnings Details
10/28/2014Q314($0.62)($0.37)$146.20 million$179.00 millionViewN/AView Earnings Details
7/29/2014Q214($0.71)($0.61)$131.85 million$138.42 millionViewListenView Earnings Details
5/1/2014Q114($0.68)($0.65)$134.46 million$118.50 millionViewN/AView Earnings Details
1/29/2014Q413($0.49)($0.56)$221.08 million$351.20 millionViewListenView Earnings Details
10/29/2013Q413($0.33)($0.32)$278.80 million$222.00 millionViewN/AView Earnings Details
7/29/2013Q2 2013($0.18)($0.26)$308.02 million$310.80 millionViewN/AView Earnings Details
4/30/2013Q1 2013($0.06)$0.03$307.85 million$328.40 millionViewN/AView Earnings Details
1/29/2013Q4 2012($0.07)($0.35)$318.53 million$334.00 millionViewN/AView Earnings Details
11/1/2012Q312$0.34$0.13$377.14 million$336.00 millionViewN/AView Earnings Details
7/30/2012$0.68$0.46ViewN/AView Earnings Details
4/26/2012$0.57$0.43ViewN/AView Earnings Details
2/2/2012$0.76$0.74ViewN/AView Earnings Details
10/27/2011$0.17$0.70ViewN/AView Earnings Details
7/28/2011($1.00)($0.67)ViewN/AView Earnings Details
5/3/2011($1.09)($0.91)ViewN/AView Earnings Details
2/3/2011($0.93)($0.74)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Vertex Pharmaceuticals (NASDAQ:VRTX)
Current Year EPS Consensus Estimate: $0.93 EPS
Next Year EPS Consensus Estimate: $2.92 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20161$0.16$0.16$0.16
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Vertex Pharmaceuticals (NASDAQ:VRTX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/29/2013quarterly$0.402/20/20133/13/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Vertex Pharmaceuticals (NASDAQ:VRTX)
Insider Ownership Percentage: 1.90%
Institutional Ownership Percentage: 96.19%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/28/2016Joshua S BogerDirectorSell6,500$88.15$572,975.00View SEC Filing  
9/21/2016Joshua S BogerDirectorSell6,500$90.82$590,330.00View SEC Filing  
9/14/2016Joshua S BogerDirectorSell6,500$92.37$600,405.00View SEC Filing  
9/7/2016Joshua S BogerDirectorSell6,500$95.66$621,790.00View SEC Filing  
8/31/2016Joshua S BogerDirectorSell6,500$94.62$615,030.00View SEC Filing  
8/24/2016Joshua S BogerDirectorSell7,500$100.46$753,450.00View SEC Filing  
8/22/2016Joshua S BogerDirectorSell1,100$100.79$110,869.00View SEC Filing  
8/17/2016Joshua S BogerDirectorSell6,900$99.63$687,447.00View SEC Filing  
8/11/2016Joshua S BogerDirectorSell900$100.19$90,171.00View SEC Filing  
8/10/2016Joshua S BogerDirectorSell7,100$100.24$711,704.00View SEC Filing  
8/3/2016Joshua S BogerDirectorSell47,000$100.66$4,731,020.00View SEC Filing  
7/27/2016Joshua S BogerDirectorSell6,500$95.93$623,545.00View SEC Filing  
7/20/2016Joshua S BogerDirectorSell6,500$90.33$587,145.00View SEC Filing  
7/13/2016Joshua S BogerDirectorSell6,500$88.81$577,265.00View SEC Filing  
7/6/2016Joshua S BogerDirectorSell5,140$88.99$457,408.60View SEC Filing  
6/29/2016Joshua S BogerDirectorSell5,130$84.82$435,126.60View SEC Filing  
6/22/2016Joshua S BogerDirectorSell5,130$86.61$444,309.30View SEC Filing  
6/15/2016Joshua S BogerDirectorSell5,130$91.18$467,753.40View SEC Filing  
6/8/2016Joshua S BogerDirectorSell5,130$94.95$487,093.50View SEC Filing  
6/1/2016Joshua S BogerDirectorSell5,130$93.65$480,424.50View SEC Filing  
5/25/2016Joshua S BogerDirectorSell5,130$89.09$457,031.70View SEC Filing  
5/18/2016Joshua S BogerDirectorSell5,130$81.18$416,453.40View SEC Filing  
5/16/2016Amit SachdevEVPSell117$81.67$9,555.39View SEC Filing  
5/16/2016Ian F SmithCFOSell202$82.06$16,576.12View SEC Filing  
5/11/2016Joshua S BogerDirectorSell5,130$86.50$443,745.00View SEC Filing  
5/9/2016Paul M SilvaSVPSell3,000$87.63$262,890.00View SEC Filing  
5/4/2016Joshua S BogerDirectorSell5,130$81.02$415,632.60View SEC Filing  
4/27/2016Joshua S BogerDirectorSell5,130$83.67$429,227.10View SEC Filing  
4/20/2016Joshua S BogerDirectorSell5,130$84.10$431,433.00View SEC Filing  
4/13/2016Joshua S BogerDirectorSell5,130$84.27$432,305.10View SEC Filing  
4/6/2016Joshua S BogerDirectorSell5,130$89.56$459,442.80View SEC Filing  
3/30/2016Joshua S BogerDirectorSell5,130$78.83$404,397.90View SEC Filing  
3/23/2016Joshua S BogerDirectorSell5,130$81.38$417,479.40View SEC Filing  
3/16/2016Joshua S BogerDirectorSell5,130$79.65$408,604.50View SEC Filing  
3/2/2016Joshua S BogerDirectorSell5,130$91.80$470,934.00View SEC Filing  
2/24/2016Joshua S BogerDirectorSell5,130$85.25$437,332.50View SEC Filing  
2/17/2016Joshua S. BogerDirectorSell5,130$86.93$445,950.90View SEC Filing  
2/10/2016Joshua S. BogerDirectorSell5,130$82.57$423,584.10View SEC Filing  
2/3/2016Ian F. SmithCFOSell12,084$90.84$1,097,710.56View SEC Filing  
2/3/2016Jeffrey M. LeidenCEOSell9,834$90.82$893,123.88View SEC Filing  
2/3/2016Joshua S. BogerDirectorSell5,130$90.81$465,855.30View SEC Filing  
2/3/2016Paul M. SilvaSVPSell5,062$90.82$459,730.84View SEC Filing  
2/3/2016Stuart A. ArbuckleEVPSell6,042$90.82$548,734.44View SEC Filing  
2/2/2016Jeffrey ChodakewitzCMOSell2,375$91.38$217,027.50View SEC Filing  
1/27/2016Joshua S. BogerDirectorSell11,200$93.22$1,044,064.00View SEC Filing  
1/20/2016Joshua S. BogerDirectorSell10,400$93.69$974,376.00View SEC Filing  
1/13/2016Joshua S. BogerDirectorSell10,400$98.41$1,023,464.00View SEC Filing  
1/6/2016Joshua S. BogerDirectorSell10,400$121.96$1,268,384.00View SEC Filing  
1/4/2016Yuchun LeeDirectorSell1,125$122.21$137,486.25View SEC Filing  
12/30/2015Joshua S. BogerDirectorSell10,400$127.15$1,322,360.00View SEC Filing  
12/21/2015Joshua S. BogerDirectorSell10,400$119.26$1,240,304.00View SEC Filing  
12/9/2015Joshua S. BogerDirectorSell10,400$120.80$1,256,320.00View SEC Filing  
12/4/2015Stuart A. ArbuckleEVPSell4,531$123.98$561,753.38View SEC Filing  
12/2/2015Joshua S. BogerDirectorSell10,400$130.91$1,361,464.00View SEC Filing  
12/1/2015David AltshulerEVPSell5,000$131.00$655,000.00View SEC Filing  
12/1/2015Yuchun LeeDirectorSell1,125$129.65$145,856.25View SEC Filing  
11/23/2015Joshua S. BogerDirectorSell10,400$132.18$1,374,672.00View SEC Filing  
11/11/2015Joshua S. BogerDirectorSell10,400$118.59$1,233,336.00View SEC Filing  
11/4/2015Joshua S. BogerDirectorSell10,400$124.23$1,291,992.00View SEC Filing  
11/2/2015Yuchun LeeDirectorSell1,125$126.19$141,963.75View SEC Filing  
10/28/2015Joshua S. BogerDirectorSell10,400$119.01$1,237,704.00View SEC Filing  
10/21/2015Joshua S. BogerDirectorSell10,400$108.82$1,131,728.00View SEC Filing  
10/14/2015Joshua S. BogerDirectorSell10,400$112.62$1,171,248.00View SEC Filing  
10/7/2015Joshua S. BogerDirectorSell10,400$109.61$1,139,944.00View SEC Filing  
10/2/2015Elaine UllianDirectorSell20,000$110.00$2,200,000.00View SEC Filing  
10/1/2015Stuart A. ArbuckleEVPSell12,417$104.71$1,300,184.07View SEC Filing  
10/1/2015Yuchun LeeDirectorSell1,125$104.64$117,720.00View SEC Filing  
9/30/2015Joshua S. BogerDirectorSell10,400$103.14$1,072,656.00View SEC Filing  
9/23/2015Joshua S. BogerDirectorSell10,400$111.89$1,163,656.00View SEC Filing  
9/16/2015Joshua S. BogerDirectorSell10,400$133.24$1,385,696.00View SEC Filing  
9/9/2015Joshua S. BogerDirectorSell10,400$131.41$1,366,664.00View SEC Filing  
9/4/2015Stuart A. ArbuckleEVPSell9,063$125.77$1,139,853.51View SEC Filing  
9/2/2015Joshua S. BogerDirectorSell10,400$125.85$1,308,840.00View SEC Filing  
9/1/2015Yuchun LeeDirectorSell1,125$125.40$141,075.00View SEC Filing  
8/26/2015Joshua S. BogerDirectorSell10,400$124.71$1,296,984.00View SEC Filing  
8/19/2015Joshua S. BogerDirectorSell10,400$139.93$1,455,272.00View SEC Filing  
8/12/2015Joshua S BogerDirectorSell10,400$135.83$1,412,632.00View SEC Filing  
7/22/2015Joshua S BogerDirectorSell10,400$130.92$1,361,568.00View SEC Filing  
7/15/2015Joshua S BogerDirectorSell12,200$133.98$1,634,556.00View SEC Filing  
7/13/2015Paul M SilvaSVPSell1,125$123.79$139,263.75View SEC Filing  
7/8/2015Joshua S BogerDirectorSell11,700$122.74$1,436,058.00View SEC Filing  
7/2/2015Jeffrey ChodakewitzCMOSell2,291$129.36$296,363.76View SEC Filing  
7/1/2015Joshua S BogerDirectorSell11,700$125.60$1,469,520.00View SEC Filing  
6/24/2015Joshua S BogerDirectorSell11,700$130.41$1,525,797.00View SEC Filing  
6/17/2015Joshua S BogerDirectorSell11,700$123.90$1,449,630.00View SEC Filing  
6/10/2015Joshua S BogerDirectorSell11,700$125.02$1,462,734.00View SEC Filing  
5/20/2015Joshua S BogerDirectorSell11,700$126.73$1,482,741.00View SEC Filing  
5/6/2015Joshua S BogerDirectorSell11,700$122.79$1,436,643.00View SEC Filing  
5/5/2015Paul M SilvaSVPSell4,101$123.68$507,211.68View SEC Filing  
4/29/2015Joshua S BogerDirectorSell11,700$124.59$1,457,703.00View SEC Filing  
4/27/2015Paul M SilvaSVPSell1,125$129.74$145,957.50View SEC Filing  
4/27/2015Stuart A ArbuckleEVPSell61,480$129.36$7,953,052.80View SEC Filing  
4/27/2015Terrence C KearneyDirectorSell68,125$129.11$8,795,618.75View SEC Filing  
4/22/2015Joshua S BogerDirectorSell11,700$132.46$1,549,782.00View SEC Filing  
4/15/2015Joshua S BogerDirectorSell11,700$129.25$1,512,225.00View SEC Filing  
4/13/2015Paul M SilvaSVPSell1,125$128.60$144,675.00View SEC Filing  
4/8/2015Joshua S BogerDirectorSell11,700$123.26$1,442,142.00View SEC Filing  
4/6/2015Margaret G McglynnDirectorSell12,500$118.36$1,479,500.00View SEC Filing  
4/2/2015Jeffrey ChodakewitzCMOSell2,291$115.50$264,610.50View SEC Filing  
4/1/2015Joshua S BogerDirectorSell11,700$115.87$1,355,679.00View SEC Filing  
3/25/2015Joshua S BogerDirectorSell11,700$120.76$1,412,892.00View SEC Filing  
3/23/2015Amit SachdevEVPSell17,083$132.28$2,259,739.24View SEC Filing  
3/23/2015Ian F SmithCFOSell6,042$125.67$759,298.14View SEC Filing  
3/23/2015Paul M SilvaSVPSell2,250$125.65$282,712.50View SEC Filing  
3/18/2015Amit SachdevEVPSell12,000$130.00$1,560,000.00View SEC Filing  
2/5/2015Paul M SilvaSVPSell1,688$109.75$185,258.00View SEC Filing  
2/4/2015Joshua S BogerDirectorSell5,700$108.81$620,217.00View SEC Filing  
2/3/2015Paul M SilvaSVPSell2,063$108.89$224,640.07View SEC Filing  
2/2/2015Jeffrey ChodakewitzCMOSell1,188$109.60$130,204.80View SEC Filing  
1/28/2015Joshua S BogerDirectorSell10,688$122.78$1,312,272.64View SEC Filing  
1/26/2015Paul M SilvaSVPSell1,125$125.62$141,322.50View SEC Filing  
1/21/2015Joshua S BogerDirectorSell10,500$125.08$1,313,340.00View SEC Filing  
1/14/2015Joshua S BogerDirectorSell10,500$120.16$1,261,680.00View SEC Filing  
1/9/2015Amit SachdevEVPSell12,000$125.00$1,500,000.00View SEC Filing  
1/9/2015Bruce I SachsDirectorSell9,861$125.04$1,233,019.44View SEC Filing  
1/7/2015Joshua S BogerDirectorSell10,500$119.32$1,252,860.00View SEC Filing  
1/2/2015Jeffrey ChodakewitzCMOSell2,291$122.54$280,739.14View SEC Filing  
12/22/2014Joshua S BogerDirectorSell10,500$117.65$1,235,325.00View SEC Filing  
12/17/2014Joshua S BogerDirectorSell10,500$110.66$1,161,930.00View SEC Filing  
12/15/2014Jeffrey M LeidenCEOSell50,017$114.97$5,750,454.49View SEC Filing  
12/12/2014Paul M SilvaSVPSell2,813$120.08$337,785.04View SEC Filing  
11/28/2014Amit SachdevEVPSell12,000$120.00$1,440,000.00View SEC Filing  
11/28/2014Bruce I SachsDirectorSell10,000$120.03$1,200,300.00View SEC Filing  
11/28/2014Paul M SilvaSVPSell8,164$119.85$978,455.40View SEC Filing  
11/26/2014Joshua S BogerDirectorSell10,500$114.54$1,202,670.00View SEC Filing  
11/6/2014Bruce I SachsDirectorSell9,900$115.21$1,140,579.00View SEC Filing  
11/5/2014Bruce I SachsDirectorSell30,100$112.62$3,389,862.00View SEC Filing  
11/3/2014Joshua S BogerDirectorSell127,411$112.20$14,295,514.20View SEC Filing  
10/29/2014Joshua S BogerDirectorSell10,500$109.44$1,149,120.00View SEC Filing  
10/28/2014Amit SachdevEVPSell12,000$115.00$1,380,000.00View SEC Filing  
10/28/2014David AltshulerDirectorSell2,000$114.75$229,500.00View SEC Filing  
10/28/2014Jeffrey ChodakewitzCMOSell3,438$115.00$395,370.00View SEC Filing  
10/27/2014Paul M SilvaSVPSell1,125$110.03$123,783.75View SEC Filing  
10/13/2014Paul M SilvaSVPSell1,125$107.89$121,376.25View SEC Filing  
10/7/2014Jeffrey ChodakewitzCMOSell3,436$104.26$358,237.36View SEC Filing  
10/6/2014David AltshulerDirectorSell1,405$109.75$154,198.75View SEC Filing  
10/1/2014Elaine UllianDirectorSell5,000$107.74$538,700.00View SEC Filing  
10/1/2014Stuart A ArbuckleEVPSell12,417$107.71$1,337,435.07View SEC Filing  
9/30/2014Amit SachdevSVPSell86,000$112.68$9,690,480.00View SEC Filing  
9/30/2014Ian F SmithCFOSell108,026$112.68$12,172,369.68View SEC Filing  
9/30/2014Jeffrey M LeidenCEOSell200,000$112.69$22,538,000.00View SEC Filing  
9/30/2014Kenneth L HortonEVPSell36,000$112.69$4,056,840.00View SEC Filing  
9/29/2014David AltshulerDirectorSell2,500$114.75$286,875.00View SEC Filing  
9/24/2014Joshua S BogerDirectorSell5,200$109.21$567,892.00View SEC Filing  
9/19/2014David AltshulerDirectorSell5,000$102.25$511,250.00View SEC Filing  
9/19/2014Paul M SilvaSVPSell25,408$99.85$2,536,988.80View SEC Filing  
9/19/2014Stuart A ArbuckleEVPSell55,521$100.00$5,552,100.00View SEC Filing  
9/17/2014Joshua S BogerDirectorSell5,200$93.62$486,824.00View SEC Filing  
9/10/2014Joshua S BogerDirectorSell5,200$94.42$490,984.00View SEC Filing  
9/5/2014David AltshulerDirectorSell2,500$94.75$236,875.00View SEC Filing  
9/3/2014Joshua S BogerDirectorSell5,200$92.79$482,508.00View SEC Filing  
8/27/2014Joshua S BogerDirectorSell5,200$93.31$485,212.00View SEC Filing  
8/20/2014Joshua S BogerDirectorSell5,200$91.51$475,852.00View SEC Filing  
8/13/2014Joshua S BogerDirectorSell5,200$88.00$457,600.00View SEC Filing  
8/6/2014Joshua S BogerDirectorSell5,200$86.54$450,008.00View SEC Filing  
7/31/2014David AltshulerDirectorSell5,000$89.59$447,950.00View SEC Filing  
7/31/2014Paul M SilvaSVPSell2,027$88.97$180,342.19View SEC Filing  
7/30/2014Joshua S BogerDirectorSell5,200$92.17$479,284.00View SEC Filing  
7/15/2014Wayne Joseph RileyDirectorSell4,800$96.65$463,920.00View SEC Filing  
7/1/2014Elaine UllianDirectorSell5,000$95.21$476,050.00View SEC Filing  
7/1/2014Kenneth L HortonEVPSell30,134$95.22$2,869,359.48View SEC Filing  
6/24/2014Megan E PaceSVPSell12,734$98.03$1,248,314.02View SEC Filing  
6/24/2014Wayne Joseph RileyDirectorSell15,000$98.03$1,470,450.00View SEC Filing  
6/16/2014Peter MuellerEVPSell7,500$68.31$512,325.00View SEC Filing  
6/9/2014Elaine UllianDirectorSell2,500$75.00$187,500.00View SEC Filing  
5/14/2014Peter MuellerEVPSell7,500$67.45$505,875.00View SEC Filing  
5/2/2014Megan PaceSVPSell1,000$67.62$67,620.00View SEC Filing  
4/15/2014Peter MuellerEVPSell7,500$61.63$462,225.00View SEC Filing  
4/9/2014Elaine UllianDirectorSell2,500$70.00$175,000.00View SEC Filing  
3/21/2014Bruce SachsDirectorSell8,700$74.59$648,933.00View SEC Filing  
3/17/2014Peter MuellerEVPSell7,500$78.29$587,175.00View SEC Filing  
2/7/2014Jeffrey LeidenCEOSell35,944$80.00$2,875,520.00View SEC Filing  
1/22/2014Bruce SachsDirectorSell8,300$84.47$701,101.00View SEC Filing  
1/21/2014Megan PaceSVPSell1,250$85.00$106,250.00View SEC Filing  
1/16/2014Jeffrey LeidenCEOSell45,000$80.00$3,600,000.00View SEC Filing  
1/15/2014Peter MuellerEVPSell7,500$78.67$590,025.00View SEC Filing  
12/23/2013Bruce SachsDirectorSell8,300$73.02$606,066.00View SEC Filing  
12/16/2013Peter MuellerEVPSell7,500$64.69$485,175.00View SEC Filing  
12/12/2013Jeffrey LeidenCEOSell9,834$65.48$643,930.32View SEC Filing  
12/12/2013Kenneth HortonEVPSell4,532$65.46$296,664.72View SEC Filing  
12/12/2013Megan PaceSVPSell5,083$65.48$332,834.84View SEC Filing  
12/4/2013Joshua BogerDirectorSell1,400$67.48$94,472.00View SEC Filing  
11/25/2013Joshua BogerDirectorSell1,400$66.89$93,646.00View SEC Filing  
11/20/2013Bruce SachsDirectorSell8,300$65.28$541,824.00View SEC Filing  
11/19/2013Joshua BogerDirectorSell1,400$62.31$87,234.00View SEC Filing  
11/5/2013Joshua BogerDirectorSell1,400$65.64$91,896.00View SEC Filing  
10/29/2013Joshua S BogerDirectorSell1,400$75.42$105,588.00View SEC Filing  
10/29/2013Thomas ConnollySVPSell1,688$75.04$126,667.52View SEC Filing  
10/24/2013Bruce I SachsDirectorSell8,300$77.06$639,598.00View SEC Filing  
10/23/2013Joshua S BogerDirectorSell1,400$76.77$107,478.00View SEC Filing  
10/16/2013Joshua S BogerDirectorSell1,400$75.41$105,574.00View SEC Filing  
10/15/2013Peter MuellerEVPSell7,500$73.25$549,375.00View SEC Filing  
10/14/2013Paul SilvaSVPSell1,593$71.87$114,488.91View SEC Filing  
10/9/2013Joshua BogerDirectorSell1,400$72.35$101,290.00View SEC Filing  
9/25/2013Joshua BogerDirectorSell1,400$74.72$104,608.00View SEC Filing  
9/18/2013Joshua BogerDirectorSell1,400$77.43$108,402.00View SEC Filing  
9/16/2013Peter MuellerEVPSell7,500$77.22$579,150.00View SEC Filing  
9/11/2013Joshua BogerDirectorSell1,400$79.61$111,454.00View SEC Filing  
9/4/2013Joshua BogerDirectorSell1,400$75.45$105,630.00View SEC Filing  
8/29/2013Bruce SachsDirectorSell8,300$77.19$640,677.00View SEC Filing  
8/28/2013Joshua BogerDirectorSell1,400$76.24$106,736.00View SEC Filing  
8/21/2013Joshua BogerDirectorSell1,400$76.96$107,744.00View SEC Filing  
8/15/2013Peter MuellerEVPSell7,500$77.41$580,575.00View SEC Filing  
8/14/2013Joshua BogerDirectorSell1,400$77.18$108,052.00View SEC Filing  
8/7/2013Joshua BogerDirectorSell1,400$77.84$108,976.00View SEC Filing  
8/5/2013Paul SilvaSVPSell3,001$78.90$236,778.90View SEC Filing  
7/31/2013Joshua S BogerDirectorSell1,400$80.89$113,246.00View SEC Filing  
7/29/2013Wayne Joseph RileyDirectorSell9,800$80.09$784,882.00View SEC Filing  
7/25/2013Paul M SilvaSVPSell1,125$86.49$97,301.25View SEC Filing  
7/24/2013Bruce I SachsDirectorSell8,300$85.50$709,650.00View SEC Filing  
7/19/2013Amit SachdevSVPSell22,250$88.69$1,973,352.50View SEC Filing  
7/18/2013Joshua S BogerDirectorSell1,400$86.12$120,568.00View SEC Filing  
7/16/2013Paul M SilvaSVPSell2,063$86.25$177,933.75View SEC Filing  
7/15/2013Christiana StamoulisSVPSell1,125$86.35$97,143.75View SEC Filing  
7/15/2013Peter MuellerEVPSell7,500$86.34$647,550.00View SEC Filing  
7/12/2013Megan E PaceSVPSell10,678$85.00$907,630.00View SEC Filing  
7/11/2013Joshua S BogerDirectorSell1,400$83.83$117,362.00View SEC Filing  
7/8/2013Kenneth L HortonEVPSell1,813$80.72$146,345.36View SEC Filing  
7/8/2013Megan E PaceSVPSell28,703$80.89$2,321,785.67View SEC Filing  
7/5/2013Christiana StamoulisSVPSell4,687$81.21$380,631.27View SEC Filing  
7/3/2013Joshua S BogerDirectorSell1,400$80.20$112,280.00View SEC Filing  
7/2/2013Peter MuellerEVPSell122,300$79.80$9,759,540.00View SEC Filing  
6/26/2013Joshua S BogerDirectorSell1,400$78.59$110,026.00View SEC Filing  
6/21/2013Bruce I SachsDirectorSell8,300$75.93$630,219.00View SEC Filing  
6/19/2013Joshua S BogerDirectorSell1,400$79.11$110,754.00View SEC Filing  
6/12/2013Joshua S BogerDirectorSell1,400$81.19$113,666.00View SEC Filing  
6/5/2013Joshua S BogerDirectorSell1,400$77.15$108,010.00View SEC Filing  
5/30/2013Joshua S BogerDirectorSell1,400$82.47$115,458.00View SEC Filing  
5/22/2013Joshua S BogerDirectorSell1,400$79.72$111,608.00View SEC Filing  
5/15/2013Joshua S BogerDirectorSell1,400$79.36$111,104.00View SEC Filing  
5/14/2013Bruce I SachsDirectorSell60,000$81.15$4,869,000.00View SEC Filing  
12/26/2012Joshua S BogerDirectorSell4,000$41.86$167,440.00View SEC Filing  
11/7/2012Margaret G McglynnDirectorBuy1,000$45.50$45,500.00View SEC Filing  
10/8/2012Ian F SmithCFOSell44,787$60.00$2,687,220.00View SEC Filing  
10/3/2012Joshua S BogerDirectorSell4,000$57.74$230,960.00View SEC Filing  
9/5/2012Joshua S BogerDirectorSell4,000$54.70$218,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Vertex Pharmaceuticals (NASDAQ:VRTX)
DateHeadline
News IconVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Updated Broker Ratings (NASDAQ:VRTX)
crcconnection.com - September 29 at 7:54 PM
forbes.com logoRSI Alert: Vertex Pharmaceuticals (VRTX) Now Oversold (NASDAQ:VRTX)
www.forbes.com - September 29 at 6:34 PM
nasdaq.com logoVertex Says FDA Approves ORKAMBI; Cuts 2016 ORKAMBI Revenue Guidance (NASDAQ:VRTX)
www.nasdaq.com - September 29 at 7:01 AM
bizjournals.com logo​Vertex confirms fears that latest drug launch is slower than hoped (NASDAQ:VRTX)
www.bizjournals.com - September 29 at 7:00 AM
News IconResearch Report for: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) (NASDAQ:VRTX)
magseriesusa.net - September 28 at 7:47 PM
fool.com logo3 Critical FDA Decisions You Can't Afford to Miss (NASDAQ:VRTX)
www.fool.com - September 27 at 7:56 PM
marketrealist.com logoHow Much Revenue May Vertex Generate in the Long Term? (NASDAQ:VRTX)
marketrealist.com - September 26 at 8:00 PM
marketrealist.com logoHigher Discontinuations Are among Orkambi’s Concerns (NASDAQ:VRTX)
marketrealist.com - September 26 at 8:00 PM
nasdaq.com logoFirst Week of VRTX November 18th Options Trading (NASDAQ:VRTX)
www.nasdaq.com - September 21 at 7:31 PM
News IconTime To Put On The Watch List? - 22nd Century Group, Inc. (NYSEMKT:XXII), Vertex Pharmaceuticals Incorporated ... - The Voice Registrar (NASDAQ:VRTX)
voiceregistrar.com - September 21 at 11:53 AM
nasdaq.com logoFirst Week of VRTX November 18th Options Trading - NASDAQ.com - Nasdaq (NASDAQ:VRTX)
www.nasdaq.com - September 21 at 11:53 AM
wsj.com logo[$$] Chilled Vertex Could Heat Up Quickly (NASDAQ:VRTX)
www.wsj.com - September 21 at 11:53 AM
wsj.com logoChilled Vertex Could Heat Up Quickly (NASDAQ:VRTX)
www.wsj.com - September 20 at 2:51 PM
News IconQ4 2016 EPS Estimates for Vertex Pharmaceuticals Inc. (VRTX) Cut ... - NewsDen (NASDAQ:VRTX)
newsden.net - September 20 at 6:37 AM
blogs.barrons.com logoM&A: Acquirers Love Dividends Too (NASDAQ:VRTX)
blogs.barrons.com - September 19 at 7:53 PM
News IconVertex Pharmaceuticals Inc. (VRTX) Price Target Raised to $109.00 at Stifel Nicolaus (NASDAQ:VRTX)
magseriesusa.net - September 17 at 6:55 AM
News IconVertex Pharmaceuticals (NASDAQ:VRTX) Receives Buy Rating From Stifel Nicolaus Analysts (NASDAQ:VRTX)
thelakeandeswave.com - September 17 at 6:55 AM
rttnews.com logoVertex Pharmaceuticals (VRTX) Fell After Slowdown In Orkambi Refills - RTT News (NASDAQ:VRTX)
www.rttnews.com - September 16 at 7:43 PM
News IconVertex Pharmaceuticals (NASDAQ:VRTX) Receives Buy Rating From Stifel Nicolaus Analysts - Cosumnes Connection (subscription) (NASDAQ:VRTX)
crcconnection.com - September 16 at 11:40 AM
marketwatch.com logoVertex Pharma stock drops 5% after company predicts slower Q3 - MarketWatch (NASDAQ:VRTX)
www.marketwatch.com - September 16 at 11:40 AM
barrons.com logo[$$] Vertex Looks to Cash In On Its Rich Drug Pipeline (NASDAQ:VRTX)
www.barrons.com - September 16 at 11:40 AM
finance.yahoo.com logoVertex: News Creates Opportunity in Shares (NASDAQ:VRTX)
finance.yahoo.com - September 15 at 8:08 PM
finance.yahoo.com logoVertex Stock Tumbles (NASDAQ:VRTX)
finance.yahoo.com - September 14 at 8:13 PM
capitalcube.com logoVertex Pharmaceuticals, Inc. – Value Analysis (NASDAQ:VRTX) : September 14, 2016 (NASDAQ:VRTX)
www.capitalcube.com - September 14 at 8:13 PM
marketwatch.com logoVertex Pharma stock drops 5% after company predicts slower Q3 (NASDAQ:VRTX)
www.marketwatch.com - September 14 at 8:13 PM
blogs.barrons.com logoWhy Vertex Pharmaceuticals is Tanking (NASDAQ:VRTX)
blogs.barrons.com - September 14 at 8:13 PM
finance.yahoo.com logoThe Market In 5 Minutes: Huge FDA News, Major Mid-Week M&A (NASDAQ:VRTX)
finance.yahoo.com - September 14 at 12:23 PM
News IconTrading the Biotech News: PDL BioPharma, Inc. (NASDAQ:PDLI), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - The Voice Registrar (NASDAQ:VRTX)
voiceregistrar.com - September 10 at 7:19 AM
publicnow.com logoVertex to Present at Upcoming Investor Conferences (NASDAQ:VRTX)
www.publicnow.com - September 9 at 7:37 PM
News IconBest stocks of the day: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) (NASDAQ:VRTX)
www.crcconnection.com - September 8 at 11:55 AM
News IconIntraday Active Biotech Stocks News: Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Vertex Pharmaceuticals ... - The Voice Registrar (NASDAQ:VRTX)
voiceregistrar.com - September 3 at 6:58 AM
News IconHC Stocks to Path - Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), IDEXX Laboratories, Inc. (NASDAQ:IDXX) - share market updates (press release) (NASDAQ:VRTX)
sharemarketupdates.com - September 1 at 11:21 AM
fidaily.com logoInsiders Are Selling – Vertex Pharmaceuticals Incorpor (NASDAQ:VRTX) (NASDAQ:VRTX)
www.fidaily.com - August 26 at 7:45 PM
News IconShares Moving Higher for the Quarter: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) (NASDAQ:VRTX)
magseriesusa.net - August 26 at 11:01 AM
finance.yahoo.com logoBiotech's next big deal? (NASDAQ:VRTX)
finance.yahoo.com - August 22 at 8:05 PM
News IconAnalysts Valuations For Two Stocks: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Xilinx, Inc. (NASDAQ:XLNX) - The Voice Registrar (NASDAQ:VRTX)
voiceregistrar.com - August 18 at 8:24 PM
finance.yahoo.com logoThe Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen (NASDAQ:VRTX)
finance.yahoo.com - August 18 at 11:18 AM
News IconVertex Dumps Phase III Cystic Fibrosis Study (NASDAQ:VRTX)
www.pharmalive.com - August 16 at 8:15 PM
rttnews.com logoVertex Pharmaceuticals Inc. (VRTX) Is Losing Ground After VX-661 Update (NASDAQ:VRTX)
www.rttnews.com - August 16 at 11:32 AM
investors.com logoVertex Stock Slips On Drug Trial Failure, Though Not A Surprise (NASDAQ:VRTX)
www.investors.com - August 16 at 11:32 AM
finance.yahoo.com logoVertex (VRTX) To Stop VX-661-Ivacaftor Study, Stock Down (NASDAQ:VRTX)
finance.yahoo.com - August 16 at 11:32 AM
rttnews.com logoVertex Pharmaceuticals Inc. (VRTX) Is Losing Ground After VX-661 Update - RTT News (NASDAQ:VRTX)
www.rttnews.com - August 15 at 8:33 PM
finance.yahoo.com logo4:07 pm Vertex Pharma updates on its Phase 3 development program of its VX-661 in combination with ivacaftor; plans to stop the study of VX-661 and ivacaftor in people with one copy of the F508del mutation after DSMB review (NASDAQ:VRTX)
finance.yahoo.com - August 15 at 8:33 PM
publicnow.com logoVertex Provides Update on Ongoing Phase 3 Program for VX-661 in Combination with Ivacaftor for the Treatment of Cystic Fibrosis (NASDAQ:VRTX)
www.publicnow.com - August 15 at 8:33 PM
cnbc.com logoAfter-hours buzz: HAIN, FN, VRTX & more (NASDAQ:VRTX)
www.cnbc.com - August 15 at 8:33 PM
feeds.benzinga.com logoVertex Pharmaceuticals' Phase 3 Studies Offer Ample Opportunity For Upside (NASDAQ:VRTX)
feeds.benzinga.com - August 15 at 4:27 PM
News IconRhenman Partners Asset Management Ab Lowers stake in Vertex Pharmaceuticals Incorporated (VRTX) (NASDAQ:VRTX)
myhealthbowl.com - August 11 at 11:39 AM
fool.com logoThese 2 Catalysts Lifted Vertex Pharmaceuticals Incorporated 13% in July (NASDAQ:VRTX)
www.fool.com - August 10 at 12:25 PM
sg.finance.yahoo.com logoAstraZeneca bets another $140 million on Moderna's 'messenger' drugs (NASDAQ:VRTX)
sg.finance.yahoo.com - August 10 at 11:26 AM
News IconActive biotech company shares in the news: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Clovis Oncology ... - The Voice Registrar (NASDAQ:VRTX)
voiceregistrar.com - August 9 at 8:32 PM

Social

Vertex Pharmaceuticals (NASDAQ:VRTX) Chart for Saturday, October, 1, 2016


Last Updated on 10/1/2016 by MarketBeat.com Staff